IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome

A Trautmann, M Vivarelli, S Samuel, D Gipson… - Pediatric …, 2020 - Springer
Idiopathic nephrotic syndrome newly affects 1–3 per 100,000 children per year.
Approximately 85% of cases show complete remission of proteinuria following …

Calcineurin inhibitor nephrotoxicity

M Naesens, DRJ Kuypers, M Sarwal - Clinical Journal of the …, 2009 - journals.lww.com
The use of the calcineurin inhibitors cyclosporine and tacrolimus led to major advances in
the field of transplantation, with excellent short-term outcome. However, the chronic …

[HTML][HTML] Model-informed precision dosing: State of the art and future perspectives

IK Minichmayr, E Dreesen, M Centanni, Z Wang… - Advanced drug delivery …, 2024 - Elsevier
Abstract Model-informed precision dosing (MIPD) stands as a significant development in
personalized medicine to tailor drug dosing to individual patient characteristics. MIPD moves …

PharmGKB summary: cyclosporine and tacrolimus pathways

JM Barbarino, CE Staatz… - Pharmacogenetics …, 2013 - journals.lww.com
Tacrolimus (FK506) and cyclosporine (cyclosporin A, CsA) are cornerstone
immunosuppressive agents administered to solid organ transplant recipients to prevent and …

Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence

N Issa, A Kukla, HN Ibrahim - American journal of nephrology, 2013 - karger.com
Background: There is no doubt that acute calcineurin inhibitor (CNI) nephrotoxicity exists;
however, chronic CNI nephrotoxicity is questionable at best. Methods: We reviewed the …

New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug …

H de Jonge, M Naesens… - Therapeutic drug …, 2009 - journals.lww.com
Although therapeutic drug monitoring (TDM) of immunosuppressive drugs has been an
integral part of routine clinical practice in solid organ transplantation for many years …

[PDF][PDF] An overview of immunosuppression in solid organ transplantation

C Enderby, CA Keller - Am J Manag Care, 2015 - ajmc.s3.amazonaws.com
Significant advancements in solid organ transplantation immunosuppressive medications
and regimens have resulted in improved outcomes over the years. A multidrug approach …

Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs

A Egli, S Köhli, M Dickenmann, HH Hirsch - Transplantation, 2009 - journals.lww.com
Background. Reducing immunosuppression is the treatment of choice for polyomavirus-
associated nephropathy in kidney transplant (KT) patients, but strategies and targets are …

Pharmacogenetics and immunosuppressive drugs in solid organ transplantation

T Van Gelder, RH Van Schaik… - Nature Reviews …, 2014 - nature.com
The transplantation literature includes numerous papers that report associations between
polymorphisms in genes encoding metabolizing enzymes and drug transporters, and …

Understanding the role of chronopharmacology for drug optimization: what do we know?

A Fujimura, K Ushijima - Expert Review of Clinical Pharmacology, 2023 - Taylor & Francis
Introduction Circadian rhythm influences the pharmacokinetics and pharmacodynamics of a
number of drugs and affects their therapeutic efficacy and toxicity depending on the time of …